Myriad Genetics Inc. Revenue 2009–2025
Myriad Genetics Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Myriad Genetics Inc. revenue for the quarter ending March 31, 2026 was 200.4 M, a 2.30% increase year-over-year.
- Myriad Genetics Inc. revenue for the twelve months ending March 31, 2026 was 815.1 M, a 0.46% decrease year-over-year.
- Myriad Genetics Inc. annual revenue for 2025 was 824.5 M, a 1.56% decrease from 2024.
- Myriad Genetics Inc. annual revenue for 2024 was 837.6 M, a 11.21% increase from 2023.
- Myriad Genetics Inc. annual revenue for 2023 was 753.2 M, a 11.03% increase from 2022.
- Myriad Genetics Inc. annual revenue for 2022 was 678.4 M.
Myriad Genetics Inc. (MYGN) — Frequently Asked Questions
Myriad Genetics Inc. (MYGN) is a publicly traded US company. It has a market capitalization of $410M. In fiscal 2025 it reported revenue of $825M and net income of -$366M. Explore MYGN's stock price, financial statements, earnings history, margins and key ratios below.
What is Myriad Genetics Inc.'s market cap?
Myriad Genetics Inc. (MYGN) has a market capitalization of $410M.
What is the MYGN stock price?
MYGN trades at $4.43 (-2.42% on the day).
How much revenue does Myriad Genetics Inc. make?
Myriad Genetics Inc. reported revenue of $825M in fiscal 2025.
Is MYGN profitable?
In fiscal 2025, Myriad Genetics Inc. reported net income of -$366M.